DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Ruof J, Klein G, Maerz W, Wollschlaeger H, Neiss A, Wehling M.
Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patterns.
Preventive Medicine 2002; 35: 48-53
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.